Scroll composite having amphiphilic substance inside and method for preparation of the same

US2016355401A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016355401-A1
Application numberUS-201515117575-A
CountryUS
Kind codeA1
Filing dateMar 2, 2015
Priority dateMar 4, 2014
Publication dateDec 8, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided are a scroll preparing method using a two-dimensional material and a scroll prepared thereby. The scroll preparing method comprises preparing a two-dimensional material. The two-dimensional material is scrolled by providing an amphiphilic substance having a hydrophilic portion and a hydrophobic portion on the two-dimensional material. As a result, a scroll composite including the amphiphilic substance disposed inside a scroll structure is formed.

First claim

Opening claim text (preview).

1 . A scroll composite, comprising: a two-dimensional material scroll with open ends; and an amphiphilic substance disposed inside the scroll. 2 . The composite of claim 1 , wherein the two-dimensional material is a single substance selected from the group consisting of graphene, graphene oxide, boron nitride, boron carbon nitride (BCN), tungsten oxide (WO 3 ), tungsten sulfide (WS 2 ), molybdenum sulfide (MoS 2 ), molybdenum telluride (MoTe 2 ), and manganese oxide (MnO 2 ), or a composite substance including a stack of two or more thereof. 3 . The composite of claim 1 , wherein the amphiphilic substance is a surfactant, a bile acid, a bile acid salt, a hydrate of a bile acid salt, a bile acid ester, a bile acid derivative, or a bacteriophage. 4 . The composite of claim 3 , wherein the surfactant includes one or more compounds selected from the group consisting of sodium dodecyl sulfate (SDS), ammonium lauryl sulfate, sodium laureth sulfate, alkyl benzene sulfonate, cetyl trimethylammonium bromide (CTAB), hexadecyl trimethyl ammonium bromide, an alkyltrimethylammonium salt, cetylpyridinium chloride (CPCl), polyethoxylated tallow amine (POEA), benzalkonium chloride (BAC), benzethonium chloride (BZT), dodecyl betaine, dodecyl dimethylamine oxide, cocamidopropyl betaine, alkyl poly(ethylene oxide), a poloxamer, a poloxamine, alkyl polyglucoside, cetyl alcohol, sodium deoxycholate, cocamide MEA, cocamide DEA, sorbitan ester, polyoxyethylene sorbitan fatty acid ester, sucrose fatty acid ester, polyethyelene glycol hydroxystearate, polyoxyethylene glycolated natural or hydrogenated castor oil, a polyoxyethylene-polyoxypropylene copolymer, a synthetic vitamin E derivative, polyoxyethylene alkyl ester, fatty acid microgol glyceride, polyglyceryl fatty acid ester, and a silicone-based surfactant. 5 . The composite of claim 3 , wherein the bile acid is represented by Formula 1 as follows: where R 1 and R 2 are each independently —H or —OH, R 3 is —(CONH—(CH 2 ) n1 ) n2 —Y 1 , n1 is 1 or 2, n2 is 1 or 0, and Y 1 is —COOH or —SO 3 H. 6 . The composite of claim 5 , wherein the bile acid is at least one selected from the group consisting of cholic acid, chenodeoxycholic acid, deoxycholic acid, lithocholic acid, glycocholic acid, taurocholic acid, glycochenodeoxycholic acid, taurochenodeoxycholic acid, glycodeoxycholic acid, taurodeoxycholic acid, glycolithocholic acid, and taurolithocholic acid. 7 . The composite of claim 5 , wherein the bile acid salt is sodium glycochenodeoxycholate, sodium taurochenodeoxycholate, sodium taurocholate, sodium dehydrocholate, or sodium deoxycholate. 8 . The composite of claim 5 , wherein the hydrate of the bile acid salt is sodium taurocholate hydrate or sodium cholate hydrate. 9 . The composite of claim 3 , wherein the bile acid derivative is represented by Formula 2 below: where n is 0, 1 or 2, and R 4 to R 7 are each independently a group represented by Formula 3, B 1  m L 1  n G 1   [Formula 3] where B 1 is one group selected from the group consisting of L 1 is a linker of —W 1 —, -Q 1 -, -Q 2 -W 2 —, —W 2 -Q 1 -W 3 —, or —W 4 -Q 2 -W 5 -Q 3 -Q 6 -, W 1 , W 2 , W 3 , W 4 , W 5 , and W 6 are each independently a 1 to a 3 are each an integer of 1 to 4, Q 1 , Q 2 , Q 3 , Q 4 , Q 5 , and Q 6 are each independently G 1 is a group represented by and m is 0 or 1, and n is 0 or 1. 10 . The composite of claim 9 , wherein the bile acid derivative is any one of Formulas 4 to 20: (R)—N-(aminomethyl)-4-((3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamide (R)-methyl-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate (R)-4-((3R,5R,8R,9S,103, 13R,14S,17R)-3-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-N-(hydroxymethyl)pentanamide (R)—N-(aminomethyl)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamide (R)-4-((3R,5R,7R,8R,9S,10S,13R,14S,17R)-7-hydroxy-10,13-dimethyl-3-(sulfooxy)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid 5β-cholanic acid-3α,12α-diol 3-acetate methyl ester 5β-cholanic acid-3-one 5β-cholanic acid 3,7-dione methyl ester 5β-cholanic acid-3,7-dione Carbamic(4R)-4-((3R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic anhydride 3R,7R,8R,9S,10S,12S,13R,14S,17R)-7,12-dihydroxy-10,13-dimethyl-17-((R)-5-((2-methyl-3-oxobutan-2-yl)amino)-5-oxopentan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthrene-3-sulfonic acid R)-4-oxo-7-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)octanenitrile 3-((R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)propanoic acid (R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic sulfuric anhydride (R)—N-carbamoyl-4-((3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamide 4-((S)-1-((3R,5R,8R,9S,10S,12S,13S,1

Assignees

Inventors

Classifications

  • Oxidation · CPC title

  • extending in two dimensions, e.g. plate-like · CPC title

  • Oxides; Hydroxides · CPC title

  • obtained by TEM, STEM, STM or AFM · CPC title

  • one of the carbon atoms being part of an amide group · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016355401A1 cover?
Provided are a scroll preparing method using a two-dimensional material and a scroll prepared thereby. The scroll preparing method comprises preparing a two-dimensional material. The two-dimensional material is scrolled by providing an amphiphilic substance having a hydrophilic portion and a hydrophobic portion on the two-dimensional material. As a result, a scroll composite including the amphi…
Who is the assignee on this patent?
Industry-Univ Coop Found Hanyang Univ
What technology area does this patent fall under?
Primary CPC classification C01B32/182. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Dec 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).